Featured Publications
Estimates of Mortality Benefit From Ideal Cardiovascular Health Metrics: A Dose Response Meta‐Analysis
Aneni EC, Crippa A, Osondu CU, Valero‐Elizondo J, Younus A, Nasir K, Veledar E. Estimates of Mortality Benefit From Ideal Cardiovascular Health Metrics: A Dose Response Meta‐Analysis. Journal Of The American Heart Association 2017, 6: e006904. PMID: 29269350, PMCID: PMC5779012, DOI: 10.1161/jaha.117.006904.Peer-Reviewed Original ResearchConceptsIdeal cardiovascular healthIdeal CVH metricsPooled hazard ratioCVH metricsCardiovascular healthMortality benefitHazard ratioCardiovascular disease-related mortalityDose–response meta analysisStrong public health messageIdeal cardiovascular health metricsSubstantial mortality benefitCardiovascular health metricsCardiovascular disease mortalityLinear dose-response relationshipDisease-related mortalityPublic health messagesHazard ratio estimatesDose-response relationshipUnit increaseWeb of ScienceCause mortalityInternet literature searchDisease mortalityCardiovascular disease
2016
A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations
Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, Malik R, Ali SS, Aziz M, Feldman T, Virani SS, Maziak W, Agatston AS, Veledar E, Nasir K. A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. Mayo Clinic Proceedings 2016, 91: 649-670. PMID: 27040086, DOI: 10.1016/j.mayocp.2016.01.019.Peer-Reviewed Original ResearchConceptsIdeal CVH metricsNon-CVD outcomesIdeal cardiovascular health metricsCVH metricsIdeal cardiovascular healthCardiovascular healthLow prevalenceAmerican Heart Association ideal cardiovascular health (CVH) metricsSystematic reviewMore ideal CVH metricsIncident cardiovascular eventsCardiovascular health metricsPopulation-based studyNon-US populationsCochrane RegisterCardiovascular eventsControlled TrialsUS cohortInverse associationCardiovascular diseaseCINAHL databasesMortality riskMortality studyCognitive impairmentUS population